Galderma Agrees to Buy ZO Skin Health for $1.5 Billion
Galderma Group agreed to buy ZO Skin Health from Blackstone, the Obagi family and other shareholders for $1.5 billion, including debt, to expand its premium skincare portfolio.
The company behind skincare brands Cetaphil and Alastin said Wednesday that the all-ca…